Cellular Biomedicine Group Company Profile (NASDAQ:CBMG)

About Cellular Biomedicine Group

Cellular Biomedicine Group logoCellular Biomedicine Group, Inc. (CBMG) is a biomedicine company. The Company is engaged in the development of treatments for cancerous and degenerative diseases utilizing cell-based technologies. The Company operates in Biomedicine Cell Therapy segment. The Company's technology includes platforms, such as Immune Cell therapy for treatment of broad range of cancers using Vaccine, T Cells Receptor (TCR) clonality analysis technology and T Central Memory Cell (Tcm) preparation methodologies, Chimeric Antigen Receptor T cell (CAR-T), and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases, with primary research and manufacturing facilities in China. It is focused on developing and marketing cell-based therapies based on its cellular platforms, to treat serious chronic and degenerative diseases, such as cancer, orthopedic diseases, including osteoarthritis and tissue damage, various inflammatory diseases and metabolic diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBMG
  • CUSIP:
Key Metrics:
  • Previous Close: $12.15
  • 50 Day Moving Average: $12.56
  • 200 Day Moving Average: $13.45
  • 52-Week Range: $11.00 - $20.98
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.65
  • P/E Growth: 0.00
  • Market Cap: $175.29M
  • Outstanding Shares: 14,251,000
  • Beta: 2.86
Profitability:
  • Net Margins: -2,272.04%
  • Return on Equity: -36.06%
  • Return on Assets: -34.25%
Debt:
  • Current Ratio: 23.61%
  • Quick Ratio: 23.48%
Additional Links:
Companies Related to Cellular Biomedicine Group:

Analyst Ratings

Consensus Ratings for Cellular Biomedicine Group (NASDAQ:CBMG) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.00 (46.34% upside)

Analysts' Ratings History for Cellular Biomedicine Group (NASDAQ:CBMG)
Show:
DateFirmActionRatingPrice TargetDetails
1/17/2017Maxim GroupSet Price TargetBuy$18.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Cellular Biomedicine Group (NASDAQ:CBMG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2017        
3/14/2016Q415($0.42)($0.43)$1.50 millionViewN/AView Earnings Details
11/13/2015Q3($0.43)($0.44)ViewN/AView Earnings Details
8/14/2015Q215($0.37)($0.44)ViewN/AView Earnings Details
5/18/2015Q115($0.40)($0.39)ViewN/AView Earnings Details
3/31/2015($0.32)($0.57)ViewN/AView Earnings Details
11/19/2014Q314($0.31)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cellular Biomedicine Group (NASDAQ:CBMG)
Current Year EPS Consensus Estimate: $-2.06 EPS
Next Year EPS Consensus Estimate: $-1.85 EPS

Dividends

Dividend History for Cellular Biomedicine Group (NASDAQ:CBMG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cellular Biomedicine Group (NASDAQ:CBMG)
Insider Ownership Percentage: 7.30%
Institutional Ownership Percentage: 9.01%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/22/2016Andrew K ChanSVPSell1,307$18.22$23,813.54View SEC Filing  
2/17/2016Andrew K. ChanSVPSell1,516$17.76$26,924.16View SEC Filing  
1/21/2016Andrew K. ChanSVPSell2,812$12.90$36,274.80View SEC Filing  
12/21/2015Andrew K. ChanSVPSell12,812$21.94$281,095.28View SEC Filing  
11/23/2015Andrew K. ChanSVPSell5,332$20.64$110,052.48View SEC Filing  
10/21/2015Wei (William) CaoCEOSell20,000$19.59$391,800.00View SEC Filing  
10/20/2015Andrew K. ChanSVPSell5,215$20.20$105,343.00View SEC Filing  
9/21/2015Andrew K. ChanSVPSell27,927$20.80$580,881.60View SEC Filing  
12/23/2014Pak To LeungMajor ShareholderSell142,857$14.00$1,999,998.00View SEC Filing  
6/26/2014David BolocanDirectorBuy10,000$5.00$50,000.00View SEC Filing  
5/22/2014Tony LiuCFOBuy100,000$5.00$500,000.00View SEC Filing  
7/23/2013Keith WongDirectorSell320,050$0.13$41,606.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cellular Biomedicine Group (NASDAQ:CBMG)
DateHeadline
seekingalpha.com logoCellular Biomedicine Group (CBMG) Presents at 19th Annual BIO CEO & Investor Conference (NASDAQ:CBMG)
seekingalpha.com - February 15 at 2:52 AM
nasdaq.com logoCellular Biomedicine Group (CBMG) to Present at the 19th BIO CEO & Investor Conference on February (NASDAQ:CBMG)
www.nasdaq.com - February 8 at 3:18 AM
feeds.benzinga.com logoCellular Biomedicine Group (CBMG) to Present at the 19th BIO CEO & Investor Conference on February 13, 2017 (NASDAQ:CBMG)
feeds.benzinga.com - February 7 at 9:19 AM
4-traders.com logoCELLULAR BIOMEDICINE GROUP, INC. (NASDAQ:CBMG) Files An 8-K Shareholder Director Nominations (NASDAQ:CBMG)
www.4-traders.com - January 26 at 3:19 AM
streetinsider.com logoCellular Biomedicine Group (CBMG) Gains Approval to Commence Phase I Trial for C-CAR011 in China (NASDAQ:CBMG)
www.streetinsider.com - January 9 at 10:21 PM
nasdaq.com logoCellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CALL-1) for C-CAR011 in Adult (NASDAQ:CBMG)
www.nasdaq.com - January 9 at 10:21 PM
us.rd.yahoo.com logoCellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in China (NASDAQ:CBMG)
us.rd.yahoo.com - January 9 at 9:00 AM
einnews.com logoCES 2017: All the announcements, TVs, laptops gadgets and more from the show (NASDAQ:CBMG)
brazilbusiness.einnews.com - January 4 at 5:11 PM
finance.yahoo.com logoCellular Biomedicine Group (CBMG) to Present at the 9th Annual Biotech Showcase in San Francisco (NASDAQ:CBMG)
finance.yahoo.com - January 4 at 5:11 PM
einnews.com logo15 sea turtles rescued off Cape Cod will recover in Florida (NASDAQ:CBMG)
brazilbusiness.einnews.com - January 3 at 5:49 PM
finance.yahoo.com logoCellular Biomedicine Group (CBMG) Expands Cell Production With Capacity to Produce CAR-T Therapies to Treat 10,000 Cancer Patients Annually (NASDAQ:CBMG)
finance.yahoo.com - January 3 at 11:05 AM
us.rd.yahoo.com logo8:00 am Cellular Biomedicine announces three-month interim safety data from Phase I Clinical Trial for AlloJoin off-the-shelf allogeneic stem cell therapy for knee osteoarthritis (NASDAQ:CBMG)
us.rd.yahoo.com - December 10 at 11:39 AM
finance.yahoo.com logoCellular Biomedicine Group Announces Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy for Knee Osteoarthritis (NASDAQ:CBMG)
finance.yahoo.com - December 9 at 4:27 PM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:CBMG)
biz.yahoo.com - December 8 at 4:56 PM
News IconCellular Biomedicine Group, A China-US Biopharma, Starts China Trial Of CAR-T Immunotherapy (NASDAQ:CBMG)
www.biospace.com - December 1 at 4:16 PM
News IconCBMG, a China-US Biopharma, Starts China Trial of CAR-T Immunotherapy (NASDAQ:CBMG)
www.chinabiotoday.com - November 30 at 9:13 PM
4-traders.com logoCELLULAR BIOMEDICINE GROUP, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) (NASDAQ:CBMG)
www.4-traders.com - November 30 at 7:01 AM
finance.yahoo.com logoCellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CARD-1) for C-CAR011 in Patients … (NASDAQ:CBMG)
finance.yahoo.com - November 30 at 7:01 AM
marketexclusive.com logoCELLULAR BIOMEDICINE GROUP, INC. (NASDAQ:CBMG) Files An 8-K Regulation FD Disclosure (NASDAQ:CBMG)
marketexclusive.com - November 30 at 7:01 AM
capitalcube.com logoCellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 (NASDAQ:CBMG)
www.capitalcube.com - November 30 at 7:01 AM
finance.yahoo.com logoCellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CARD-1) for C-CAR011 in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL) in China (NASDAQ:CBMG)
finance.yahoo.com - November 30 at 7:01 AM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:CBMG)
biz.yahoo.com - November 30 at 7:01 AM
marketexclusive.com logoCellular Biomedicine Group Inc. (NASDAQ:CBMG) Files An 8-K Announces Appointment of Ant Financial Vice President, Gang Ji, to the Board of Directors (NASDAQ:CBMG)
marketexclusive.com - November 16 at 4:01 PM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements (NASDAQ:CBMG)
biz.yahoo.com - November 15 at 10:44 AM
finance.yahoo.com logoCellular Biomedicine Group Announces Appointment of Ant Financial Vice President, Gang Ji, to the Board of Directors (NASDAQ:CBMG)
finance.yahoo.com - November 14 at 4:13 PM
einnews.com logoCellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights (NASDAQ:CBMG)
energy.einnews.com - November 8 at 9:40 PM
sg.finance.yahoo.com logoCellular Biomedicine reports 3Q loss (NASDAQ:CBMG)
sg.finance.yahoo.com - November 8 at 9:40 PM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CBMG)
biz.yahoo.com - November 8 at 2:49 PM
4-traders.com logoCELLULAR BIOMEDICINE GROUP, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Shareholder Director Nominations (form 8-K) (NASDAQ:CBMG)
www.4-traders.com - September 22 at 9:45 AM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, (NASDAQ:CBMG)
biz.yahoo.com - September 22 at 9:45 AM
finance.yahoo.com logoCoverage initiated on Cellular Biomedicine by Maxim Group (NASDAQ:CBMG)
finance.yahoo.com - September 22 at 9:45 AM
finance.yahoo.com logoCellular Biomedicine Group Announces Results of 2016 Annual General Meeting (NASDAQ:CBMG)
finance.yahoo.com - September 10 at 8:48 AM
biz.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation (NASDAQ:CBMG)
biz.yahoo.com - September 10 at 8:48 AM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : September 9, 2016 (NASDAQ:CBMG)
www.capitalcube.com - September 9 at 4:00 PM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : August 29, 2016 (NASDAQ:CBMG)
www.capitalcube.com - August 29 at 3:28 PM
4-traders.com logoCellular Biomedicine : Announces Dismissal of Class Action Litigation (NASDAQ:CBMG)
www.4-traders.com - August 19 at 11:39 AM
finance.yahoo.com logoCellular Biomedicine Group Announces Dismissal of Class Action Litigation (NASDAQ:CBMG)
finance.yahoo.com - August 18 at 12:31 PM
finance.yahoo.com logoCELLULAR BIOMEDICINE GROUP, INC. Financials (NASDAQ:CBMG)
finance.yahoo.com - August 17 at 4:12 PM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : August 17, 2016 (NASDAQ:CBMG)
www.capitalcube.com - August 17 at 4:12 PM
News IconCerebral Palsy Pipeline Market 2016 Global Review Research (NASDAQ:CBMG)
www.fox8live.com - August 16 at 9:22 PM
capitalcube.com logoCellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:CBMG)
www.capitalcube.com - August 15 at 4:17 PM
streetinsider.com logoCellular Biomedicine Group Reports Second Quarter and First Half 2016 Financial Results and Business Highlights (NASDAQ:CBMG)
www.streetinsider.com - August 10 at 11:46 AM
sg.finance.yahoo.com logoCellular Biomedicine reports 2Q loss (NASDAQ:CBMG)
sg.finance.yahoo.com - August 9 at 1:01 PM
finance.yahoo.com logoUPDATE -- Cellular Biomedicine Group Reports Second Quarter and First Half 2016 Financial Results and Business Highlights (NASDAQ:CBMG)
finance.yahoo.com - August 9 at 1:01 PM
finance.yahoo.com logoCellular Biomedicine Group Announces Annual General Meeting of Stockholders (NASDAQ:CBMG)
finance.yahoo.com - August 1 at 8:30 AM
4-traders.com logoCellular Biomedicine : Announces Appointment of New Member to the Board of Directors (NASDAQ:CBMG)
www.4-traders.com - July 13 at 9:30 PM
finance.yahoo.com logoCellular Biomedicine Group Announces Appointment of New Member to the Board of Directors (NASDAQ:CBMG)
finance.yahoo.com - July 12 at 8:30 AM
finance.yahoo.com logo5:27 am Cellular Biomedicine to issue up to 5,137,905 shares of common stock for sale by selling shareholders (NASDAQ:CBMG)
finance.yahoo.com - June 21 at 5:27 AM
capitalcube.com logoETF’s with exposure to Cellular Biomedicine Group, Inc. : June 17, 2016 (NASDAQ:CBMG)
www.capitalcube.com - June 17 at 5:08 PM
News IconSystemic lupus erythematosus pipeline market review 2016 insights shared in detailed report (NASDAQ:CBMG)
www.whatech.com - June 7 at 12:21 PM

Social

What is Cellular Biomedicine Group's stock symbol?

Cellular Biomedicine Group trades on the NASDAQ under the ticker symbol "CBMG."

Where is Cellular Biomedicine Group's stock going? Where will Cellular Biomedicine Group's stock price be in 2017?

1 equities research analysts have issued twelve-month target prices for Cellular Biomedicine Group's shares. Their predictions range from $18.00 to $18.00. On average, they expect Cellular Biomedicine Group's share price to reach $18.00 in the next twelve months.

When will Cellular Biomedicine Group announce their earnings?

Cellular Biomedicine Group is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

How do I buy Cellular Biomedicine Group stock?

Shares of Cellular Biomedicine Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cellular Biomedicine Group stock cost?

One share of Cellular Biomedicine Group stock can currently be purchased for approximately $12.30.

Cellular Biomedicine Group (NASDAQ:CBMG) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cellular Biomedicine Group (NASDAQ:CBMG)

Earnings History Chart

Earnings by Quarter for Cellular Biomedicine Group (NASDAQ:CBMG)

Dividend History Chart

Dividend Payments by Quarter for Cellular Biomedicine Group (NASDAQ:CBMG)

Last Updated on 2/21/2017 by MarketBeat.com Staff